Skip to main content

Table 25 Olanzapine for children and adolescents with OSFED/EDNOS

From: Canadian practice guidelines for the treatment of children and adolescents with eating disorders

Certainty assessment

Impact

Certainty

Importance

№ of studies

Study design

Risk of bias

Inconsistency

Indirectness

Imprecision

Other considerations

Global improvement (assessed with: Clinical Global Impressions Scale)

 1

Case Report

very serious a

not serious

serious b

not serious

none

Single case report of 12 year old female with EDNOS. CGI improved with olanzapine 10 mg daily.

VERY LOW

IMPORTANT

  1. Explanations
  2. asingle case report, no control
  3. boutcome measured does not really answer our clinical question
  4. Bibliography:
  5. Case Report - Bozabali 2002 [156]